Sharif Al-Ruzzeh, Jose L Navia. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Antifibrinolytic Agents/therapeutic useBiomarkersBlood Transfusion/statistics & numerical dataCardiac Surgical ProceduresCardiopulmonary Bypass/statistics & numerical dataCombined Modality TherapyConfounding Factors, EpidemiologicFactor VIIa/therapeutic useHemostatics/therapeutic useHumansPlasmaPlatelet Transfusion/statistics & numerical dataPostoperative Hemorrhage/drug therapyPostoperative Hemorrhage/therapyRandomized Controlled Trials as Topic/methodsRandomized Controlled Trials as Topic/statistics & numerical dataRecombinant Proteins/therapeutic useReoperation/statistics & numerical dataResearch Design
Substances： See more » Antifibrinolytic AgentsBiomarkersHemostaticsRecombinant Proteinsrecombinant FVIIaFactor VIIa
Year: 2010 PMID： 20212289 DOI： 10.1161/CIR.0b013e3181d68ebc
Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690